VERA: Vera Therapeutics, Inc. Company Short-Term Debt
Vera Therapeutics, Inc. (VERA) is a biotech developer creating innovative therapies for renal pathologies. Current price action reflects the impact of Atacicept's success, which could become a leader in the treatment of IgA nephropathy and attract a buyer, with the indicator standing at 0.00. The brand possesses strong scientific authority, and shareholder loyalty is based on breakthrough tests. R&D stability ensures minimal staff turnover and the targeted hiring of experts.
Metric breakdowns and analytics for Vera Corp (VERA)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Vera Therapeutics, Inc.|VERA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Vera Therapeutics, Inc.|VERA - Company Total Debt|Debt to Book Capitalization Ratio Vera Therapeutics, Inc.|VERA - Company Long-Term Liabilities|Company Current Liabilities Vera Therapeutics|Quick Liquidity veratx.com
- net income and valuation multiples indicators:
Initial company analysis:VERA - Vera Therapeutics
Short-term debts represent the aggregate of a company's obligations due for repayment within one year. By analyzing total short-term liabilities, an investor assesses current solvency and liquidity risk. This metric sums all accounts payable and short-term loans. For Vera Therapeutics, Inc. (VERA), a low debt level confirms financial stability. This is critically important for a biopharmaceutical company developing immunological drugs within a stable US scientific field.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|Company Current Liabilities ABCL|Company Short-Term Debts Tourmaline|Company Short-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|ZBIO: Company Current Liabilities|IMNM: Company Short-Term Debt|GOSS: Company Short-Term Debts|Short-Term Debt kalvista.com (KALV)|Company Short-Term Debt Septerna|PVLA: Company Short-Term Loans and Borrowings|Company Short-Term Debts SVRA|Company Short-Term Debts Rigel Corp (RIGL)|AnaptysBio, Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings ATXS|ENGN: Company Current Liabilities|rapt.com - Amount of Current Liabilities|JBIO: Company Short-Term Debts|Aclaris Therapeutics, Inc - Company Short-Term Loans and Borrowings|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|Short-Term Debt tizianalifesciences.com TLSA|Company Short-Term Debt Cabaletta Bio (CABA)|VTYX (Ventyx Biosciences Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts THTX (Theratechnologies Inc)|Company Short-Term Debts Avalo Therapeutics Inc AVTX|ELDN - Company Short-Term Debt|Current Liabilities AGEN|CLYM: Company Short-Term Debts|Short-Term Debt zurabio.com (ZURA)|Company Current Liabilities ATYR|Company Short-Term Debts Adagene Corp|Company Current Liabilities IMA (ImageneBio Inc)|Amount of Current Liabilities STTK|Company Short-Term Debts EQ (Equillium)|Short-Term Debt Volume Connect Biopharma Holdings (CNTB)|Immunic Inc - Company Short-Term Debts|Atara Biotherapeutics (ATRA) - Company Current Liabilities|inflarx.de (IFRX) - Company Short-Term Debt|XFOR - Short-Term Debt Volume|Company Current Liabilities ACET|CELU: Company Short-Term Loans and Borrowings|Company Short-Term Debts INMB|Short-Term Debt Volume Barinthus Biotherapeutics Corp|Company Short-Term Debt Kezar Life Sciences KZR|SABS: Company Short-Term Indebtedness|Akari Therapeutics Plc - Company Short-Term Debts|Enlivex Therapeutics (ENLV) - Company Current Liabilities|QTTB (q32bio.com) - Company Current Liabilities|GOVX - Short-Term Debt Volume|Company Current Liabilities EDSA|Company Short-Term Debt IBIO|Company Short-Term Debts CARM|XTLB - Short-Term Debt|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|Company Short-Term Loans and Borrowings HCWB|Aptevo - Company Short-Term Debts|AIM - Company Short-Term Debts|aditxt.com (ADTX) - Company Short-Term Debt|Current Liabilities GRI (GRI Bio Inc)|XRTX (XORTX) - Company Short-Term Debts|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|Company Short-Term Loans and Borrowings CALI|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Current Liabilities ITOS|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debts TCBP|Short-Term Debt Volume Third Harmonic Bio Inc